Profile | GDS4284 / 234644_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 706.127 | 69 |
GSM687648 | Patient 402 control | 2876.82 | 88 |
GSM687653 | Patient 403 control | 418.232 | 62 |
GSM687658 | Patient 404 control | 2548.74 | 87 |
GSM687663 | Patient 411 control | 3202.34 | 90 |
GSM687668 | Patient 422 control | 1216.5 | 77 |
GSM687673 | Patient 424 control | 1806.99 | 82 |
GSM687678 | Patient 425 control | 2145.22 | 85 |
GSM687683 | Patient 427 control | 1411.03 | 79 |
GSM687688 | Patient 428 control | 818.381 | 71 |
GSM687695 | Patient 441 control | 10827.6 | 97 |
GSM687699 | Patient 443 control | 2199.45 | 85 |
GSM687704 | Patient 444 control | 1460.89 | 80 |
GSM687707 | Patient 448 control | 563.273 | 65 |
GSM687712 | Patient 449 control | 998.073 | 74 |
GSM687719 | Patient 450 control | 3050.54 | 89 |
GSM687724 | Patient 451 control | 678.629 | 68 |
GSM687728 | Patient 452 control | 5675.98 | 94 |
GSM687646 | Patient 401 treated 24h | 380.607 | 59 |
GSM687649 | Patient 402 treated 24h | 3158.24 | 89 |
GSM687665 | Patient 411 treated 24h | 3648.92 | 91 |
GSM687651 | Patient 402 treated 4 weeks | 2439.36 | 86 |
GSM687667 | Patient 411 treated 4 weeks | 1552.09 | 80 |
GSM687670 | Patient 422 treated 24h | 1375.53 | 78 |
GSM687671 | Patient 422 treated 4 weeks | 1382.69 | 78 |
GSM687654 | Patient 403 treated 24h | 409.299 | 61 |
GSM687675 | Patient 424 treated 24h | 1889.29 | 83 |
GSM687685 | Patient 427 treated 24h | 2132.69 | 85 |
GSM687656 | Patient 403 treated 4 weeks | 367.934 | 60 |
GSM687677 | Patient 424 treated 4 weeks | 891.713 | 72 |
GSM687687 | Patient 427 treated 4 weeks | 718.861 | 69 |
GSM687692 | Patient 428 treated 4h | 1280.58 | 78 |
GSM687716 | Patient 449 treated 4h | 667.202 | 68 |
GSM687722 | Patient 450 treated 4h | 1853.75 | 83 |
GSM687680 | Patient 425 treated 24h | 1842.23 | 83 |
GSM687690 | Patient 428 treated 24h | 1176.32 | 77 |
GSM687700 | Patient 443 treated 24h | 6005.19 | 95 |
GSM687705 | Patient 444 treated 24h | 3153.58 | 89 |
GSM687714 | Patient 449 treated 24h | 1510.7 | 80 |
GSM687721 | Patient 450 treated 24h | 3148.25 | 90 |
GSM687682 | Patient 425 treated 4 weeks | 2059.13 | 84 |
GSM687694 | Patient 428 treated 4 weeks | 1269.12 | 77 |
GSM687702 | Patient 443 treated 4 weeks | 2989.33 | 89 |
GSM687718 | Patient 449 treated 4 weeks | 840.283 | 72 |
GSM687723 | Patient 450 treated 4 weeks | 1291.59 | 78 |
GSM687661 | Patient 404 treated 4h | 1745.91 | 82 |
GSM687710 | Patient 448 treated 4h | 912.841 | 73 |
GSM687726 | Patient 451 treated 4h | 598.662 | 66 |
GSM687730 | Patient 452 treated 4h | 3661.11 | 92 |
GSM687660 | Patient 404 treated 24h | 8649.2 | 96 |
GSM687697 | Patient 441 treated 24h | 7399.33 | 96 |
GSM687709 | Patient 448 treated 24h | 768.835 | 70 |
GSM687725 | Patient 451 treated 24h | 748.502 | 70 |
GSM687729 | Patient 452 treated 24h | 7556.09 | 96 |
GSM687727 | Patient 451 treated 4 weeks | 723.652 | 69 |
GSM687731 | Patient 452 treated 4 weeks | 4332.78 | 92 |